Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
53M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
13K
-
Shares change
-
-139K
-
Total reported value, excl. options
-
$14.2K
-
Value change
-
-$187K
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$1.04
Significant Holders of Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO) as of Q1 2024
8 filings reported holding MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value as of Q1 2024.
Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13K shares
of 53M outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (11.6K shares), Royal Bank of Canada (1.06K shares), NBC SECURITIES, INC. (167 shares), JPMORGAN CHASE & CO (148 shares), US BANCORP \DE\ (0 shares), Koss-Olinger Consulting, LLC (0 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), OLIVER LAGORE VANVALIN INVESTMENT GROUP (0 shares), ARMISTICE CAPITAL, LLC (210K shares), and VANGUARD GROUP INC (206K shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.